*JUVÉDERM® is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
Important JUVÉDERM® Treatment Considerations
JUVÉDERM® Ultra and JUVÉDERM® Ultra Plus are indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate lasting 7 days or less and included temporary injection site reactions like redness, pain, firmness, swelling and bumps. For more information, please click on the “About Safety” link, or call the Allergan Product Support line at 1-877-345-5372.
BOTOX® Cosmetic is approved for the temporary treatment of moderate
to severe frown lines between the brows in people ages 18-65.
Important Safety Information about BOTOX® Cosmetic
BOTOX® Cosmetic injections should not be given to people who have an infection where the physician proposes to inject. They should not be given to people who are known to be sensitive to any ingredient in BOTOX® Cosmetic.
Serious heart problems and serious allergic reactions have been reported rarely. If you think you are having an allergic reaction or other reactions, such as difficulty swallowing, speaking, or breathing, call your doctor immediately. The most common side effects following injection include temporary eyelid droop and nausea. Localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising may be associated with the injection. Patients with certain neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious side effects.
BOTOX® Cosmetic is a pharmaceutical drug administered by physicians and is available only by prescription.
Please
click here for the full product information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.

From the UK? Visit
www.allerganbeauty.co.uk©2009 Allergan, Inc. ® and ™ marks owned by Allergan, Inc.
JUVÉDERM® mark owned by Allergan Industrie SAS. MDOC-03363-02 | APC02UZ09